A 16% drop in Almonty’s share price on Friday has handed investors a sharper question than any tungsten price chart can answer: can the Sangdong mine scale fast enough to clear expectations that have just been cut?
Diamond Equity Research trimmed its near-term forecasts on 17 November, and the revision landed in two places at once. The research house marked down the tungsten price deck and pushed back the timetable on which operations are assumed to contribute. For anyone tracking the ramp-up, separating those two effects matters more than the headline revenue growth of the quarter just reported.
From 14 cents to 4: the new yardstick
The most concrete marker is the fourth-quarter 2026 earnings-per-share estimate, which Diamond Equity cut to $0.04 from $0.14. That figure is a model output, not company guidance, but it gives shareholders a fixed reference point against which the next quarterly print can be measured.
Beating it would only settle half the argument. The follow-up question is whether any outperformance came from Sangdong itself or from a friendlier tungsten price. A higher metal price can flatter results without the ramp-up moving any faster, just as a weaker one can mask genuine operational gains. Earnings per share is the first test; the explanation behind any deviation is the second.
The revision did not stop at the closing quarter. Diamond Equity also lowered its 2027 EPS estimate to $0.67 from $1.04, and its illustrative value per share now stands at $18.40. Almonty disclosed that it paid the research firm $100,000 for the commissioned analysis, a detail that puts the model-derived valuation in its proper context.
What the third quarter actually showed
Almonty’s own numbers offer a base camp rather than a summit. For the third quarter of 2026 the company reported revenue of C$41.889 million and adjusted EBITDA of C$14.586 million — group-wide figures that say nothing directly about fourth-quarter EPS. The quarter’s operational headline was that Sangdong produced tungsten for the first time in 33 years, with management saying its focus was on bringing the plant up to speed.
First output is a starting point. The more telling metric will be actual volumes achieved and how they develop across several reporting periods. On that front, Almonty has said more than 90% of Phase I production is already contracted, which removes much of the customer-finding risk as the plant lifts output. The remaining uncertainty shifts to execution: turning signed volumes into delivered tonnes.
Should investors sell immediately? Or is it worth buying Almonty?
A second outlet sits in Spain, where Almonty reported a multi-year offtake agreement with a take-or-pay structure for tungsten trioxide recovered from processing residues at Los Santos. The contracted minimum is roughly 1,720 tonnes of contained tungsten trioxide. That deal covers different material from Sangdong and broadens the sales base, though it should not be read as evidence of progress in South Korea.
The legal file running in parallel
Separate from the operating story, Deutsche Rohstoff valued its claims against Almonty in Canada at about $67 million on 17 November, centred mainly on conversion rights and outstanding loans. Almonty has filed its own suit, the proceedings have been consolidated, and the sum is a claim on the table rather than an established payment.
What would confirm the cautious case
The benign path is straightforward: Almonty holds to the revised timeline, shipments reach the income statement without further slippage, and the company meets the lowered EPS bar even under the softer price assumptions. Hitting the target that way would say more about operational momentum than a beat driven mainly by metal prices.
The risk path is equally clear. Cost pressure combined with fresh delivery delays could leave Almonty short of even the reduced estimate, and a lower tungsten price would then compound the problem. Should the ramp-up lag behind the already-cautious assumptions, contracted volumes would remain a sales advantage but no substitute for missing tonnes.
The next hard checkpoint is the fourth-quarter 2026 report, when the disclosed EPS can be set against the $0.04 estimate. Beyond that, investors will want Almonty’s own disclosures on shipments and costs to show tangible progress at Sangdong — and, for Phase II, evidence that the expansion is advancing. Only that reading will show whether a stronger quarter would also shore up the 2027 assumptions.
Ad
Almonty Stock: Buy or Sell?! New Almonty Analysis from November 21 delivers the answer:
The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 21.
Almonty: Buy or sell? Read more here...
